# Bio-art and bio-design as economic activity A genuinely thin category dominated by individual artists and grant/academic-funded studios rather than a commercial vendor market — gallery and museum-commissioned bio-design work, distinct from the functional bio-material product companies covered elsewhere on this site — one confirmed studio as of 2026. Source: https://en.bioecon.ru/technology/bio-art-design-economic-activity/ Updated: 2026-08-21 ## Overview and value chain Markers: [EC: none — general EU art/design commerce | OECD: bio-materials, cross-cutting | Regulator: REACH (EU)] Bio-art and bio-design as economic activity covers gallery- and museum-commissioned design work built around living or biologically-derived materials — most visibly grown mycelium and other biofabricated materials shaped into art objects and design pieces — as economic activity distinct from the functional bio-material product companies (packaging, leather alternatives, construction materials) already covered elsewhere on this site. This is a genuinely thin commercial category: bio-art as gallery/exhibition economic activity is dominated by individual artists and grant- or academic-funded studios (university design labs, educational competitions) rather than a broad commercial vendor market with product pages. As of 2026 only one studio was confirmed with strong, on-topic, museum-exhibition-level evidence of ongoing commissioned bio-design work. The key directions of bio-art and bio-design as economic activity are: 1. **3D-printed living-material design:** using 3D printing techniques to shape living materials like mycelium into finished design or art objects, a genuine technical innovation distinct from conventional biofabrication molding. 2. **Museum and gallery commissions:** design work commissioned specifically for exhibition in museums and galleries, generating revenue through commission fees and exhibition licensing rather than product sales. 3. **Materials-innovation design practice:** a design practice organized around pioneering new biological material applications, positioning the studio's work at the intersection of art, design, and materials science. 4. **Grant/academic-funded bio-design:** the broader field's dominant funding model — university design labs and educational competitions (e.g. the Biodesign Challenge) rather than commercial commissions. ### Sectoral value chain ``` [Material innovation R&D] ──> [Design/artwork creation] ──> [Gallery/museum commission] ──> [Exhibition installation] │ (public/critical reception) │ ▼ [Commission revenue/licensing] <─── [Exhibition run] <────────────────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Material innovation R&D** | Developing new techniques for shaping living or bio-derived materials into design objects | **In:** materials science, design practice.
**Out:** a validated fabrication technique. | | **Design/artwork creation** | Applying the fabrication technique to create a specific design or art piece | **In:** fabrication technique, artistic/design concept.
**Out:** a completed bio-design object. | | **Gallery/museum commission** | A museum or gallery commissions the work for exhibition | **In:** completed object, institutional interest.
**Out:** a commission agreement. | | **Exhibition installation** | The work is installed and presented as part of a museum or gallery exhibition | **In:** commission agreement, object.
**Out:** an installed exhibition. | | **Exhibition run** | The exhibition runs for its scheduled duration, generating public and critical reception | **In:** installed exhibition.
**Out:** public/critical reception. | | **Commission revenue/licensing** | The studio earns revenue through commission fees, exhibition licensing, or related mechanisms | **In:** exhibition run.
**Out:** studio revenue. | Cross-cutting technologies of the sector: - **3D printing of living materials:** printing techniques adapted to shape mycelium or other living biological substrates into precise design geometries. - **Biofabrication for design (not function):** materials science applied to aesthetic and conceptual design objects rather than functional commercial products. - **Museum/gallery commissioning practice:** the institutional and commercial mechanics of art/design commissioning, distinct from product manufacturing and sale. --- ## US No US studio with a dedicated, confirmed bio-art/bio-design commercial practice comparable to the EU anchor was found on a live screen. A "Biodesign Challenge studio" query surfaced only weak, single-mention evidence — the Biodesign Challenge itself is an academic/educational competition, not a commercial studio. ### Academic/educational bio-design activity, no confirmed dedicated studio - **Market context:** the US has active academic bio-design programming (e.g. the Biodesign Challenge), but this article found no confirmed US commercial studio with museum/gallery-commission-level evidence comparable to the EU anchor. - **Reopen condition:** if a US studio with confirmed commercial bio-art/bio-design commissions surfaces on a future screen, this section should be revised and the studio added to the table. --- ## CN No Chinese studio with a dedicated, confirmed bio-art/bio-design commercial practice was found on a live screen. ### No confirmed dedicated studio - **Market context:** this article found no Chinese studio with confirmed, on-topic evidence of commissioned bio-art/bio-design work. - **Reopen condition:** if a Chinese studio with confirmed bio-art/bio-design commissions surfaces on a future screen, this section should be revised and the studio added to the table. --- ## EU The EU has the one confirmed studio in this category. ### 3D-printed mycelium design, museum commissions - **Studio Klarenbeek & Dros:** a Dutch design studio confirmed via a dedicated Pinakothek der Moderne (Munich) museum exhibition, "Klarenbeek & Dros: Design of the Unusual," described by the museum as the first designers worldwide to 3D-print mycelium, alongside additional coverage from Nieuwe Instituut and German architecture press of their bio-design work. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Studio Klarenbeek & Dros** | 🇳🇱 Netherlands | *3D-printed mycelium design objects* | First designers worldwide to 3D-print living mycelium material | Active, confirmed 2026 museum exhibition | --- ## Tech stack and innovations The category's core innovation is technical fabrication method applied to artistic and design ends rather than commercial product function. 1. **3D-printed mycelium fabrication:** - Studio Klarenbeek & Dros pioneered 3D-printing mycelium, a living, thread-like fungal root structure, into precise design geometries — a genuine materials-science first credited to the studio by a major museum. 2. **Museum-exhibition-scale commissioning:** - The studio's work being commissioned for a dedicated Pinakothek der Moderne exhibition reflects the commission-and-exhibition economic model that defines this category, distinct from product manufacturing. 3. **Materials-innovation positioning:** - The studio's practice is explicitly framed around materials innovation rather than conventional design aesthetics, positioning its bio-design work at the intersection of art, design, and applied materials science. --- ## Value chains and production pipelines ### Industrial pipeline of a museum-commissioned bio-design work (general EU art/design commerce) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Material innovation R&D │ ───> │ 2. Design/artwork creation │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Exhibition installation │ <─── │ 3. Gallery/museum commission │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Exhibition run │ ───> │ 6. Commission revenue/licensing │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Material innovation R&D The studio develops a new technique for shaping a living or bio-derived material into a design object, such as the 3D-printing method for mycelium. #### Stage 2: Design/artwork creation The fabrication technique is applied to create a specific bio-design piece intended for exhibition. #### Stage 3: Gallery/museum commission A museum or gallery, such as the Pinakothek der Moderne, commissions the work for a dedicated exhibition. #### Stage 4: Exhibition installation The commissioned work is installed as part of the museum or gallery's exhibition program. #### Stage 5: Exhibition run The exhibition runs for its scheduled duration, generating public visitor engagement and critical/press reception. #### Stage 6: Commission revenue/licensing The studio earns revenue through the commission fee and any related exhibition-licensing mechanisms, closing the economic cycle for the piece. ---